Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
금요일, 9월 04

VivoPower PLC

VIVONASDAQ
Trade with Public
Trade with Public
$3.92
0.041.03%
가까이에: Sep 3, 5:00 PM EST
$3.85
-0.07-1.79%
시간외: 7:30 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

VivoPower Analyst Price Targets

Wall Street analyst price targets and consensus rating for VivoPower (VIVO).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy
Consensus RatingOutperform# Analysts1Avg. Consensus PT$10Upside to Avg. PT+159.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Jul 13, 2026Noble Capital MarketsMichael KupinskiInitiateOutperform$10

Analyst Ratings News

PRO
Noble Capital Markets Initiates Coverage On VivoPower with Outperform Rating, Announces Price Target of $10

Noble Capital Markets analyst Michael Kupinski initiates coverage on VivoPower (NASDAQ:VIVO) with a Outperform rating and announces Price Target of $10.
Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022

 
Benzinga Insights

PRO
HC Wainwright & Co. Downgrades Meridian Bioscience to Neutral, Raises Price Target to $34

HC Wainwright & Co. analyst Yi Chen downgrades Meridian Bioscience (NASDAQ:VIVO) from Buy to Neutral and raises the price target from $30 to $34.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Meridian Bioscience, Raises Price Target to $30

HC Wainwright & Co. analyst Yi Chen maintains Meridian Bioscience (NASDAQ:VIVO) with a Buy and raises the price target from $28 to $30.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Meridian Bioscience, Raises Price Target to $28

HC Wainwright & Co. analyst Yi Chen maintains Meridian Bioscience (NASDAQ:VIVO) with a Buy and raises the price target from $27 to $28.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Meridian Bioscience, Lowers Price Target to $27

HC Wainwright & Co. analyst Yi Chen maintains Meridian Bioscience (NASDAQ:VIVO) with a Buy and lowers the price target from $30 to $27.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved